Author
Listed:
- Guangchun Han
(The University of Texas MD Anderson Cancer Center)
- Ansam Sinjab
(The University of Texas MD Anderson Cancer Center)
- Zahraa Rahal
(The University of Texas MD Anderson Cancer Center)
- Anne M. Lynch
(The University of Texas MD Anderson Cancer Center
Baylor College of Medicine)
- Warapen Treekitkarnmongkol
(The University of Texas MD Anderson Cancer Center)
- Yuejiang Liu
(The University of Texas MD Anderson Cancer Center
The University of Texas Health Houston Graduate School of Biomedical Sciences)
- Alejandra G. Serrano
(The University of Texas MD Anderson Cancer Center)
- Jiping Feng
(The University of Texas MD Anderson Cancer Center)
- Ke Liang
(The University of Texas MD Anderson Cancer Center)
- Khaja Khan
(The University of Texas MD Anderson Cancer Center)
- Wei Lu
(The University of Texas MD Anderson Cancer Center)
- Sharia D. Hernandez
(The University of Texas MD Anderson Cancer Center)
- Yunhe Liu
(The University of Texas MD Anderson Cancer Center)
- Xuanye Cao
(The University of Texas MD Anderson Cancer Center)
- Enyu Dai
(The University of Texas MD Anderson Cancer Center)
- Guangsheng Pei
(The University of Texas MD Anderson Cancer Center)
- Jian Hu
(University of Pennsylvania)
- Camille Abaya
(The University of Texas MD Anderson Cancer Center)
- Lorena I. Gomez-Bolanos
(The University of Texas MD Anderson Cancer Center)
- Fuduan Peng
(The University of Texas MD Anderson Cancer Center)
- Minyue Chen
(The University of Texas MD Anderson Cancer Center
The University of Texas Health Houston Graduate School of Biomedical Sciences)
- Edwin R. Parra
(The University of Texas MD Anderson Cancer Center)
- Tina Cascone
(The University of Texas MD Anderson Cancer Center)
- Boris Sepesi
(The University of Texas MD Anderson Cancer Center)
- Seyed Javad Moghaddam
(The University of Texas MD Anderson Cancer Center)
- Paul Scheet
(The University of Texas MD Anderson Cancer Center)
- Marcelo V. Negrao
(The University of Texas MD Anderson Cancer Center)
- John V. Heymach
(The University of Texas MD Anderson Cancer Center)
- Mingyao Li
(University of Pennsylvania)
- Steven M. Dubinett
(The University of California Los Angeles)
- Christopher S. Stevenson
(Lung Cancer Initiative at Johnson & Johnson)
- Avrum E. Spira
(Lung Cancer Initiative at Johnson & Johnson
Boston University)
- Junya Fujimoto
(The University of Texas MD Anderson Cancer Center)
- Luisa M. Solis
(The University of Texas MD Anderson Cancer Center)
- Ignacio I. Wistuba
(The University of Texas MD Anderson Cancer Center)
- Jichao Chen
(The University of Texas MD Anderson Cancer Center
The University of Texas Health Houston Graduate School of Biomedical Sciences)
- Linghua Wang
(The University of Texas MD Anderson Cancer Center
The University of Texas Health Houston Graduate School of Biomedical Sciences)
- Humam Kadara
(The University of Texas MD Anderson Cancer Center
The University of Texas Health Houston Graduate School of Biomedical Sciences)
Abstract
Understanding the cellular processes that underlie early lung adenocarcinoma (LUAD) development is needed to devise intervention strategies1. Here we studied 246,102 single epithelial cells from 16 early-stage LUADs and 47 matched normal lung samples. Epithelial cells comprised diverse normal and cancer cell states, and diversity among cancer cells was strongly linked to LUAD-specific oncogenic drivers. KRAS mutant cancer cells showed distinct transcriptional features, reduced differentiation and low levels of aneuploidy. Non-malignant areas surrounding human LUAD samples were enriched with alveolar intermediate cells that displayed elevated KRT8 expression (termed KRT8+ alveolar intermediate cells (KACs) here), reduced differentiation, increased plasticity and driver KRAS mutations. Expression profiles of KACs were enriched in lung precancer cells and in LUAD cells and signified poor survival. In mice exposed to tobacco carcinogen, KACs emerged before lung tumours and persisted for months after cessation of carcinogen exposure. Moreover, they acquired Kras mutations and conveyed sensitivity to targeted KRAS inhibition in KAC-enriched organoids derived from alveolar type 2 (AT2) cells. Last, lineage-labelling of AT2 cells or KRT8+ cells following carcinogen exposure showed that KACs are possible intermediates in AT2-to-tumour cell transformation. This study provides new insights into epithelial cell states at the root of LUAD development, and such states could harbour potential targets for prevention or intervention.
Suggested Citation
Guangchun Han & Ansam Sinjab & Zahraa Rahal & Anne M. Lynch & Warapen Treekitkarnmongkol & Yuejiang Liu & Alejandra G. Serrano & Jiping Feng & Ke Liang & Khaja Khan & Wei Lu & Sharia D. Hernandez & Yu, 2024.
"An atlas of epithelial cell states and plasticity in lung adenocarcinoma,"
Nature, Nature, vol. 627(8004), pages 656-663, March.
Handle:
RePEc:nat:nature:v:627:y:2024:i:8004:d:10.1038_s41586-024-07113-9
DOI: 10.1038/s41586-024-07113-9
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:627:y:2024:i:8004:d:10.1038_s41586-024-07113-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.